Abstract
The neglected tropical diseases (NTDs) are caused by several parasites, fungi, bacteria and viruses and affect more than one billion people in the world. The control and prevention against NTDs need implementation of alternative methods for testing new compounds against these diseases. For the implementation of alternative methods, it is necessary to apply the principles of replacement, reduction and refinement (the 3Rs) for the use of laboratory animals. Accordingly, the present review addressed a variety of alternative models to study the infections caused by protozoa and fungi. Overall, vertebrate and invertebrate models of fungal infection have been used to elucidate host-pathogen interactions. However, until now the insect model has not been used in protozoal studies as an alternative method, but there is interest in the scientific community to try new tools to screen alternative drugs to control and prevent protozoal infections.
Keywords: Fungal, leishmaniasis, Chagas disease, alternative methods, alternative host models, target-based approach.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Alternative Host Models for Testing Anti-Protozoal or Antifungal Compounds and Fungal Infection
Volume: 18 Issue: 4
Author(s): Ana Claudia Torrecilhas, Patricia Xander, Karen Spadari Ferreira and Wagner Luiz Batista*
Affiliation:
- Laboratorio de Imunologia Celular e Bioquimica de Fungos e Protozoarios, Departamento de Ciencias Farmaceuticas, Universidade Federal de Sao Paulo - Campus Diadema. Rua Sao Nicolau, 210, 4º andar, 04023-900, Diadema,Brazil
Keywords: Fungal, leishmaniasis, Chagas disease, alternative methods, alternative host models, target-based approach.
Abstract: The neglected tropical diseases (NTDs) are caused by several parasites, fungi, bacteria and viruses and affect more than one billion people in the world. The control and prevention against NTDs need implementation of alternative methods for testing new compounds against these diseases. For the implementation of alternative methods, it is necessary to apply the principles of replacement, reduction and refinement (the 3Rs) for the use of laboratory animals. Accordingly, the present review addressed a variety of alternative models to study the infections caused by protozoa and fungi. Overall, vertebrate and invertebrate models of fungal infection have been used to elucidate host-pathogen interactions. However, until now the insect model has not been used in protozoal studies as an alternative method, but there is interest in the scientific community to try new tools to screen alternative drugs to control and prevent protozoal infections.
Export Options
About this article
Cite this article as:
Torrecilhas Claudia Ana, Xander Patricia , Ferreira Spadari Karen and Batista Luiz Wagner *, Alternative Host Models for Testing Anti-Protozoal or Antifungal Compounds and Fungal Infection, Current Topics in Medicinal Chemistry 2018; 18 (4) . https://dx.doi.org/10.2174/1568026618666180412154519
DOI https://dx.doi.org/10.2174/1568026618666180412154519 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Insights into Vascular Repair Mechanisms
Current Pharmaceutical Design Discovery of Cationic Polymers for Non-Viral Gene Delivery Using Combinatorial Approaches
Combinatorial Chemistry & High Throughput Screening Molecular Targets for Promoting Wound Healing in Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Animal Models for Studying Neointima Formation
Current Vascular Pharmacology Nitric Oxide-Dependent Neovascularization Role in the Lower Extremity Disease
Current Pharmaceutical Design Reduction of Myocardial Ischemia-Reperfusion Injury with Pre- and Postconditioning: Molecular Mechanisms and Therapeutic Targets
Cardiovascular & Hematological Disorders-Drug Targets Absorption, Disposition and Pharmacokinetics of Nanoemulsions
Current Drug Metabolism Editorial [Hot Topic: Matrix Metalloproteinases in Cardiovascular Disease (Guest Editors: N. Papageorgiou & D. Tousoulis)]
Current Topics in Medicinal Chemistry Subject Index To Volume 2
Current Cardiology Reviews The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer
Current Drug Targets Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management
Current Diabetes Reviews Diabetes-induced Epigenetic Signature in Vascular Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Diabetic CVD – Focus on Vitamin D
Cardiovascular & Hematological Agents in Medicinal Chemistry Is There a True Beneficial Effect of Statin Therapy in the Acute Phase of Unstable Angina or Myocardial Infarction?
Current Vascular Pharmacology Hyperhomocysteinaemia: A Critical Review of Old and New Aspects
Current Drug Metabolism Cardio-Renal-Anemia Syndrome: A Link Between Erythropoietin, Dimethylarginine and Homocysteine
Current Medicinal Chemistry Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Severe Preeclampsia
Current Women`s Health Reviews Repair of Dilated Aortic Root and Sinotubular Junction Using a Stabilizer Ring
Recent Patents on Cardiovascular Drug Discovery Anti-atherosclerotic Effects of Spice-Derived Phytochemicals
Current Medicinal Chemistry